180 Life Sciences
Biotechnology
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate,combination therapy.

$4.1M

Market Cap • 12/6/2024

2016

(8 years)
Founded

2017

(7 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Palo Alto

Headquarters • California

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions
  • ...and much more!

    Get Premium